Rhenman & Partners Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-4,392
| Closed | -$756K | – | 99 |
|
|
2021
Q3 | $756K | Sell |
4,392
-195,608
| -98% | -$33.7M | 0.05% | 92 |
|
|
2021
Q2 | $25.1M | Buy |
200,000
+40,000
| +25% | +$5.02M | 1.7% | 17 |
|
|
2021
Q1 | $21.7M | Hold |
160,000
| – | – | 1.51% | 25 |
|
|
2020
Q4 | $20.5M | Buy |
160,000
+15,000
| +10% | +$1.92M | 1.67% | 22 |
|
|
2020
Q3 | $16.3M | Sell |
145,000
-10,000
| -6% | -$1.13M | 1.45% | 30 |
|
|
2020
Q2 | $14.8M | Buy |
155,000
+85,000
| +121% | +$8.1M | 1.6% | 26 |
|
|
2020
Q1 | $6.29M | Sell |
70,000
-30,000
| -30% | -$2.7M | 0.88% | 44 |
|
|
2019
Q4 | $5.3M | Buy |
100,000
+30,000
| +43% | +$1.59M | 0.58% | 62 |
|
|
2019
Q3 | $2.77M | Hold |
70,000
| – | – | 0.35% | 70 |
|
|
2019
Q2 | $2.88M | Hold |
70,000
| – | – | 0.32% | 68 |
|
|
2019
Q1 | $3.26M | Buy |
+70,000
| New | +$3.26M | 0.38% | 67 |
|